• About us
• Contact

Advertisement

Organisation › Details

Bico (Group)

Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health. The Group’s products are trusted by more than 2,000 laboratories, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 1,850 publications. BICO is listed on Nasdaq Stockholm under BICO. *

 

	Start	2021-08-12 renamed
	Industry	3D bioprinting
	Person	Gatenholm, Erik (Cellink 201908 CEO + Co-Founder)
	Person 2	Danielsson, Gusten (Cellink 201908–202204 CFO + Co-Founder LEFT 4/22)
	Region	Göteborg (Gothenburg)
	Country	Sweden
	City	n. a.
		Address record changed: 2021-09-23
Basic data	Employees	D: 101 to 500 (2019-08-31)
	Currency	SEK
	Annual sales	105,457,000 (sales, net, consolidated (2018/19) 2019-08-31)
	Profit	581,000 (2019-08-31)
	Cash	198,770,000 (2019-08-31)
		* Document for »About Section«: Bico Group AB. (8/23/21). "Press Release: Dispendix Welcomes Petros Apostolopoulos as New CEO to Strengthen Position as Leading Liquid Handling and Lab Automation Company".
		Record changed: 2022-08-08

Advertisement

More documents for Bico (Group)

• [1] Bico Group AB. (2/27/23). "Press Release: Bico Introduces New Life Sciences Manufacturing Platform Integrating ABB Robotics Technology"....
• [2] Bico Group AB. (1/2/23). "Press Release: Bico Group Appoints New CFO"....
• [3] Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen....
• [4] Scienion GmbH. (7/28/22). "Press Release: Scienion Announces Expansion in the UK with the Opening of New R&D and Manufacturing Facilities". Lakeside North Harbour, Portsmouth....
• [5] Scienion GmbH. (7/5/22). "Press Release: Highfield Diagnostics and Scienion Sign Memorandum of Understanding". Southampton & Berlin....
• [6] Scienion GmbH. (6/1/22). "Press Release: Scienion Appoints Frauke Hein as CEO". Berlin....
• [7] Bico Group AB. (5/6/22). "Press Release: Bico Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored products"....
• [8] Bico Group AB. (4/29/22). "Press Release: New Interim CFO at BICO"....
• [9] Bico Group AB. (4/26/22). "Press Release: BICO’s CFO Gusten Danielsson Leaves His Assignment"....
• [10] Bico Group AB. (12/16/21). "Press Release: Bico Has Entered into an Agreement to Acquire Biosero, a Leading Software Provider for Automated Workflows and Laboratory Connectivity"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.